• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥马珠单抗治疗囊性纤维化儿童的变应性支气管肺曲霉病:已发表证据的综合分析

Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.

作者信息

Tanou Kalliopi, Zintzaras Elias, Kaditis Athanasios G

机构信息

Pediatric Pulmonology Unit, First Department of Pediatrics, University of Athens School of Medicine and Aghia Sophia Children's Hospital, Athens, Greece.

出版信息

Pediatr Pulmonol. 2014 May;49(5):503-7. doi: 10.1002/ppul.22937. Epub 2013 Oct 25.

DOI:10.1002/ppul.22937
PMID:24167019
Abstract

Allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF) is treated with corticosteroids. Since elevated IgE is a cardinal abnormality, anti-IgE has been used sporadically as adjuvant treatment. In eight case reports, 13 children with CF and ABPA received anti-IgE resulting in improved FEV1 , fewer respiratory symptoms and decreased corticosteroid use.

摘要

变应性支气管肺曲霉病(ABPA)合并囊性纤维化(CF)采用皮质类固醇进行治疗。由于IgE升高是一项主要异常,抗IgE已偶尔用作辅助治疗。在8篇病例报告中,13例患有CF和ABPA的儿童接受了抗IgE治疗,结果FEV1改善、呼吸道症状减少且皮质类固醇使用量降低。

相似文献

1
Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.奥马珠单抗治疗囊性纤维化儿童的变应性支气管肺曲霉病:已发表证据的综合分析
Pediatr Pulmonol. 2014 May;49(5):503-7. doi: 10.1002/ppul.22937. Epub 2013 Oct 25.
2
Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.奥马珠单抗治疗伴有囊性纤维化的激素依赖型变应性支气管肺曲霉病(ABPA)
Paediatr Respir Rev. 2013 Mar;14(1):22-4. doi: 10.1016/j.prrv.2012.11.004. Epub 2013 Jan 1.
3
Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.抗IgE抗体治疗一名囊性纤维化患者的变应性支气管肺曲霉病
Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1839-41.
4
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2013 Sep 17(9):CD010288. doi: 10.1002/14651858.CD010288.pub2.
5
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.
6
Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.奥马珠单抗:囊性纤维化患者过敏性支气管肺曲霉病的一种新治疗选择。
Ther Adv Respir Dis. 2014 Oct;8(5):141-9. doi: 10.1177/1753465814547517. Epub 2014 Aug 21.
7
Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.奥马珠单抗治疗囊性纤维化合并变应性支气管肺曲霉病的年轻患者。
Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10.
8
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.针对囊性纤维化患者的过敏性支气管肺曲霉病的抗IgE治疗。
Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD010288. doi: 10.1002/14651858.CD010288.pub4.
9
Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.针对囊性纤维化患者过敏性支气管肺曲霉病的奥马珠单抗病例系列。
Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.
10
Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.奥马珠单抗治疗囊性纤维化患者的变应性支气管肺曲霉病
Ann Pharmacother. 2016 Mar;50(3):188-93. doi: 10.1177/1060028015624204. Epub 2015 Dec 23.

引用本文的文献

1
Treatment of allergic bronchopulmonary aspergillosis with biologics.使用生物制剂治疗变应性支气管肺曲霉病。
Chin Med J Pulm Crit Care Med. 2025 Jan 10;3(1):6-11. doi: 10.1016/j.pccm.2024.11.005. eCollection 2025 Mar.
2
in Children and Young People with Cystic Fibrosis: A Narrative Review.针对患有囊性纤维化的儿童和青少年:一项叙述性综述。
J Fungi (Basel). 2025 Mar 9;11(3):210. doi: 10.3390/jof11030210.
3
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.
变应性支气管肺曲霉病患者使用生物制剂的疗效:系统评价和荟萃分析。
Lung. 2024 Aug;202(4):367-383. doi: 10.1007/s00408-024-00717-y. Epub 2024 Jun 19.
4
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.修订的 ISHAM-ABPA 工作组临床实践指南,用于诊断、分类和治疗变应性支气管肺曲霉病/真菌病。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.00061-2024. Print 2024 Apr.
5
Management of comorbidities in difficult and severe asthma.重度和难治性哮喘共病的管理
Breathe (Sheff). 2023 Sep;19(3):230133. doi: 10.1183/20734735.0133-2023. Epub 2023 Nov 14.
6
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review.生物制剂治疗囊性纤维化患者变应性支气管肺曲霉病的系统评价。
Eur Respir Rev. 2022 Jul 27;31(165). doi: 10.1183/16000617.0011-2022. Print 2022 Sep 30.
7
Emerging Fungal Threats in Cystic Fibrosis.囊性纤维化中的真菌新威胁。
Mycopathologia. 2021 Oct;186(5):639-653. doi: 10.1007/s11046-021-00574-w. Epub 2021 Jul 28.
8
Allergic bronchopulmonary Aspergillosis in children.儿童变应性支气管肺曲霉病。
Turk J Med Sci. 2021 Oct;51(5):2554-2563. doi: 10.3906/sag-2104-227. Epub 2021 Jun 24.
9
Human(ized) monoclonal antibodies in atopic patients - state of the art.特应性患者中的人源化单克隆抗体——最新进展
Cent Eur J Immunol. 2020;45(2):195-201. doi: 10.5114/ceji.2020.97909. Epub 2020 Jul 27.
10
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.奥马珠单抗用于囊性纤维化患者的变应性支气管肺曲霉病治疗
J Asthma Allergy. 2018 Jun 19;11:101-107. doi: 10.2147/JAA.S156049. eCollection 2018.